Breaking
Wednesday, June 17, 2026
Dr. Elena Marsh

Dr. Elena Marsh PharmD

🇺🇸 FDA

Senior Pharma Markets Correspondent

1 published article Editorial team Editorial policy

Quick answer

Dr. Elena Marsh is a Senior Pharma Markets Correspondent for United States & Americas pharmaceutical intelligence editor on NovaPharmaNews, with 1 published article covering FDA regulatory actions, clinical development, and market-moving news. Elena Marsh covers oncology and renal therapeutics for NovaPharmaNews. She holds a PharmD and spent six years as a clinical pharmacist before moving into pharmaceutical market analysis, reporting on immuno-oncology and HIF pathway drugs since 2020.

About Dr. Elena Marsh

Elena Marsh covers oncology and renal therapeutics for NovaPharmaNews. She holds a PharmD and spent six years as a clinical pharmacist before moving into pharmaceutical market analysis, reporting on immuno-oncology and HIF pathway drugs since 2020.

Coverage focus

Topics and beats Dr. covers across United States & Americas.

Explore related intelligence

Entity directories linked from this author's coverage.

Articles by Dr. Elena Marsh

Frequently asked questions

Who writes NovaPharmaNews articles?

Each story is attributed to a named editor or analyst with a public author profile. Profiles list credentials, coverage focus, and every published article so readers and AI systems can verify expertise and trace claims to a accountable journalist.

How do I find more coverage from this author?

Scroll to the article archive on this page, or use the topic chips linked from the author’s specializations. The regional authors directory lists every active contributor in this edition.

How does author coverage connect to companies and pipeline data?

Articles link to company profiles, drug INN pages, clinical trials, and pipeline programs when entities are tagged. Use the intelligence spokes on each story or browse topic hubs from the author’s beat.